Am J Physiol Cell Physiol Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Cell Physiol 264: C453-C456, 1993;
0363-6143/93 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (19)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pedersen, S. B.
Right arrow Articles by Richelsen, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pedersen, S. B.
Right arrow Articles by Richelsen, B.

AJP - Cell Physiology, Vol 264, Issue 2 C453-C456, Copyright © 1993 by American Physiological Society

ARTICLES

Inhibition of renal ornithine decarboxylase activity prevents kidney hypertrophy in experimental diabetes

S. B. Pedersen, A. Flyvbjerg and B. Richelsen
Division of Endocrinology and Metabolism, University Clinic of Internal Medicine, Aarhus Amtssygehus, Denmark.

The selective ornithine decarboxylase (ODC) inhibitor difluoromethyl ornithine (DFMO) was used to investigate the role of polyamines in initial diabetic renal enlargement. ODC activity in kidneys from diabetic animals was increased (fivefold) 24 h after diabetes induction (P < 0.05), and throughout the study (7 days) the activity remained 2- to 3-fold elevated (P < 0.05). Insulin treatment normalized renal ODC activity, whereas DFMO treatment totally inhibited the kidney ODC activity. The kidney weight in diabetic rats was 21% higher than that of control rats (1,074 +/- 35 mg and 889 +/- 16 mg, P < 0.001). Insulin treatment normalized kidney weight (847 +/- 13 mg). Despite unaltered diabetic metabolic aberrations the kidney weight in DFMO-treated diabetic rats was normalized (911 +/- 7 mg). In conclusion, the ODC activity in diabetic kidneys undergoing hypertrophy was increased. Insulin treatment normalized both kidney weight and kidney ODC activity. Finally, selective inhibition of ODC activity by DFMO resulted in kidneys of normal size, despite unaltered diabetic metabolic aberrations. These findings support the hypothesis that polyamines play an important role in initial diabetic renal enlargement.


This article has been cited by other articles:


Home page
 Am. J. Physiol. Renal Physiol.Home page
C. M. Miracle, T. Rieg, H. Mansoury, V. Vallon, and S. C. Thomson
Ornithine decarboxylase inhibitor eliminates hyperresponsiveness of the early diabetic proximal tubule to dietary salt
Am J Physiol Renal Physiol, October 1, 2008; 295(4): F995 - F1002.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
S. C. Thomson, V. Vallon, and R. C. Blantz
Kidney function in early diabetes: the tubular hypothesis of glomerular filtration
Am J Physiol Renal Physiol, January 1, 2004; 286(1): F8 - F15.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
S. Q. DOI, T. A. JACOT, D. F. SELLITTI, P. HIRSZEL, M. H. HIRATA, G. E. STRIKER, and L. J. STRIKER
Growth Hormone Increases Inducible Nitric Oxide Synthase Expression in Mesangial Cells
J. Am. Soc. Nephrol., August 1, 2000; 11(8): 1419 - 1425.
[Abstract] [Full Text]

Home page
 Nephrol Dial TransplantHome page
M. Ketteler, R. Westenfeld, A. Gawlik, E. de Heer, and A. Distler
Acute glomerular upregulation of ornithine decarboxylase is not essential for mesangial cell proliferation and matrix expansion in anti-Thy-1-nephritis
Nephrol. Dial. Transplant., January 1, 2000; 15(1): 16 - 22.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online